Results 241 to 250 of about 149,963 (343)

Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary CDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central ...
Gabriele Matteoli, Sara Alvente, Stefano Bastianini, Chiara Berteotti, Elisabetta Ciani, Elenia Cinelli, Viviana Lo Martire, Giorgio Medici, Tommaso Mello, Elena Miglioranza, Alessandro Silvani, Donatella Mutolo, Giovanna Zoccoli   +12 more
wiley   +1 more source

Prodromal Sleep Disturbances and Polysomnographic Findings in Patients With Creutzfeldt-Jakob Disease. [PDF]

Brain Behav
Demirel E, Yalcin-Cakmakli G, Yetim E, Saygi S, Tezer FI.   +4 more
europepmc   +1 more source

Early sleep apnea treatment in stroke (eSATIS) – a multicentre, randomised controlled, rater‐blinded, clinical trial: The association of post‐stroke cognition with sleep‐disordered breathing and its treatment

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Sleep‐disordered breathing (SDB) is linked to cognitive dysfunction. Although SDB is common in stroke patients, the impact of SDB and its early treatment on cognitive functioning after stroke remains poorly investigated. Therefore, we explored the association between SDB and post‐stroke cognitive functioning, including the impact of early SDB ...
Irina Filchenko, Simone B. Duss, Saskia Salzmann, Anne‐Kathrin Brill, Lyudmila Korostovtseva, Valeria Amelina, Sébastien Baillieul, Corrado Bernasconi, Markus H. Schmidt, Claudio L. A. Bassetti   +9 more
wiley   +1 more source

Clinical validation study of the Persian version of the Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire (RBDSQ-PER). [PDF]

Arq Neuropsiquiatr
Sadri M, Shakiba A, Amirifard H, Aghamollaii V.   +3 more
europepmc   +1 more source

Sex‐based disparities in dopamine agonist response in patients with restless legs syndrome

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary This study aimed to investigate sex‐related differences in the response to ropinirole and pramipexole in patients with restless legs syndrome (RLS). By analysing clinical parameters and polysomnographic (PSG) findings, we sought to elucidate the potential factors related to sex disparities modulating treatment responses and sleep quality in RLS.
Maria P. Mogavero, Elena Antelmi, Giuseppe Lanza, Sara Marelli, Alessandra Castelnuovo, Michele Tinazzi, Lourdes M. DelRosso, Rosalia Silvestri, Raffaele Ferri, Luigi Ferini Strambi   +9 more
wiley   +1 more source

Kaptin-Actin Binding Protein (KPTN)-Related Disorder: A Case Report of Two Siblings Harboring a Novel KPTN Mutation. [PDF]

Cureus
Biswas I, Fleet A, Rastanawie H, Yang S, Deif A, Bernad PG.   +5 more
europepmc   +1 more source

Decrease of excessive daytime sleepiness after shunt treatment for normal pressure hydrocephalus

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Sleepiness and apathy are often reported in patients with normal pressure hydrocephalus. However, research on outcomes after shunt surgery has mainly focused on the classical triad symptoms, that is, gait, cognition, and bladder dysfunction. This study aimed to describe the effects of shunt treatment on excessive daytime sleepiness and whether ...
Simon Lidén, Anna Lindam, Dan Farahmand, Anne‐Marie Landtblom, Katarina Laurell   +4 more
wiley   +1 more source

Effects of Treating Obstructive Sleep Apnea on Common Symptoms of HIV. [PDF]

J Acquir Immune Defic Syndr
Berry DL, Orr JE, Schmickl CN, DeYoung P, Bosompra NO, Ancoli-Israel S, Grant I, Young-Karris M, Malhotra A, Owens RL.   +9 more
europepmc   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng, Daniel Lorch, Nancy Hall, Margaret Moline   +3 more
wiley   +1 more source

A case of central sleep apnea in an adult with agenesis of the corpus callosum. [PDF]

Respir Med Case Rep
Cabriada-Nuño V, Castro-Quintas S, Urrutia-Gajate A, Tijero-Merino B.   +3 more
europepmc   +1 more source